Abstract
The world's population is increasing at an alarming rate and is projected to reach nine billion by 2050. Despite this, 15% of couples world-wide remain childless because of infertility. Few genetic causes of infertility have been identified in humans; nevertheless, genetic aetiologies are thought to underlie many cases of idiopathic infertility. Mouse models with reproductive defects as a major phenotype are being rapidly created and discovered and now total over 200. These models are helping to define mechanisms of reproductive function, as well as identify potential new contraceptive targets and genes involved in the pathophysiology of reproductive disorders. With this new information, men and women will continue to be confronted with difficult decisions on whether or not to use state-of-the-art technology and hormonal treatments to propagate their germline, despite the risks of transmitting mutant genes to their offspring.
Similar content being viewed by others
Main
Despite advances in assisted reproductive technologies, infertility is a major health problem worldwide. Approximately 15% of couples are unable to conceive within one year of unprotected intercourse. The fertility potential of a couple is dependent on the coordinated and combined functions of both male and female reproductive systems. Anatomic defects, gametogenesis dysfunction, endocrinopathies, immunologic problems, ejaculatory failure and environmental exposures are significant causes of infertility. Although several infertility disorders are associated with defined genetic syndromes (for example, cystic fibrosis and Turner's Syndrome1,2), almost a quarter of clinical infertility cases of either sex are idiopathic in nature, in part as a result of a poor understanding of the basic mechanisms regulating fertility. It is thought that genetic defects underlie many of these unrecognized pathologies. On the basis of over 200 infertile or subfertile genetic mouse models (see Supplementary Information Table; also see ref. 3), it is not surprising that the diagnosis of idiopathic infertility is common in the clinic4,5.
In this review, we discuss causes of mammalian infertility with an emphasis on the genetic basis of fertility defects in humans and mice. Animal models have defined key signalling pathways and proteins involved in reproductive physiology6. Mouse models have been produced by spontaneous mutations, fortuitous transgene integration, retroviral infection of embryonic stem cells, ethylnitrosurea (ENU) mutagenesis and gene targeting technologies3,7,8. These mutations affect all aspects of reproduction, including ovarian development and function, testis determination, spermatogenesis, sperm function, genital tract development and function, sexual behaviour, fertilization and early embryonic development, and therefore have contributed much to our understanding of infertility. For example, male infertility is observed in the spontaneous mutant models hypogonadal (hpg)9 and testicular feminization (tfm)10 and in models created by transgene integration, such as the kisimo mouse model (which arose by transgene disruption of the Theg gene11) and retroviral disruption of the Bclw12, Mtap13 and Spnr14 genes. These models are improving our knowledge of the genetic basis of mammalian infertility and suggest that in the future, clinical technologies must advance to enable analysis of many more genes when an infertile couple enters the clinic. Currently, karyotype analysis, sequence analysis of the cystic fibrosis transmembrane conductance regulator gene and Y chromosome deletion analysis (for males) are the only genetic tests commonly offered to infertile patients4,5.
Where it all begins
Reproductive development and physiology are evolutionarily conserved processes across eutherian mammalian species and many other vertebrates, including marsupials15, amphibians, reptiles, birds and fish16,17,18,19. Several genes required for vertebrate fertility are also highly conserved in evolution, with orthologues in Drosophila melanogaster (for example, vasa (DDX4), fat facets (DFFRY) and boule (DAZ)20,21,22). Propagation of the vertebrate germline requires development of the gonads, the site of future gamete production. The indifferent gonad forms during foetal development, primordial germ cells enter the gonad primordium and the tissue eventually differentiates along a female (ovarian) or male (testicular) pathway; this differentiation dictates the formation of the secondary sex organs19. Although there may be spatiotemporal variations of these processes in different species (for example, in mice and humans, gonadal sex determination occurs in utero, whereas in marsupial mammals, it occurs after birth), they eventually yield ovaries that produce eggs or testes that generate spermatozoa.
Defects in sexual differentiation pathways can cause infertility in mice and humans of both sexes (Fig. 1)23,24,25. In 1959, through the analysis of human XO (Turner syndrome) females and XXY (Kleinfelter syndrome) males, as well as XO and XX female mice and XY male mice, it was concluded that the Y chromosome was male determining26,27,28. Subsequent chromosomal and genetic studies of humans and mice with sex reversal syndromes and infertility revealed that many XX males have translocations of a small piece of the Y chromosome, so that the sex-determining region Y gene (SRY) results in testis development. Similarly, XY females often have inactivating mutations in the SRY gene, resulting in the development of ovaries29,30. A critical role of Sry in sex determination was confirmed by showing that the expression of an Sry transgene in an XX mouse causes testis formation, and physical and behavioural sex reversal31. Most SRY mutations disrupt the high mobility group (HMG) box of the SRY protein; not surprisingly, this region is highly conserved among different species32. HMG box-containing proteins typically bind and significantly bend DNA and function as transcription factors or facilitators of transcription. Several genes upstream and downstream of SRY in the sex determination pathway are now known (reviewed in ref. 23). For example, XY female sex reversal correlates with a duplication of the human X-linked gene DAX1 (ref. 33) or haploinsufficiency of the autosomal SOX9 gene32,34,35,36. Interestingly, whereas an extra Y chromosome (that is, XYY) has little effect on human male fertility because of the selected loss of the extra Y during spermatogenesis37, Klinefelter (XXY–XXXXY) males account for 10–15% of azoospermic patients38.
From a distance, they will come
In both sexes, the primordial germ cells (PGCs) are defined histologically as alkaline-phosphatase-positive embryonic cells39,40. In the mouse, these cells divide rapidly under the influence of transforming growth factor-β (TGF-β) superfamily signals; knockout models lacking bone morphogenetic protein-4 (BMP-4) or BMP-8b, or the downstream cytoplasmic-to-nuclear relay proteins, SMAD1 and SMAD5, have defects in PGC development41,42,43,44. At mid-gestation, the PGCs begin one of the longest journeys of any mammalian cell, migrating from their origin at the base of the yolk sac, along the hind-gut, to eventually enter the genital ridge. Factors required for this migration in humans are unknown, although chemoattractants and cell adhesion factors have been implicated45. In the mouse, mutations in Kit receptor (KITR) and Kit ligand (KITL) genes block PGC migration, causing infertility, but not altering sexual differentiation46.
Few known human mutations result in a reduction of the PGC or follicle pool, although girls with Turner's syndrome (partial or complete X-chromosome monosomy), have streak (remnant) gonads with no oocytes. Many Turner's syndrome cases with ovarian failure seem to be caused by loss of the short arm of the X-chromosome2. Among the candidate Turner's syndrome ovarian failure genes are ZFX, BMP15, UBE1 and USP9X (ref. 2). An absence of Zfx in mice results in a loss of germ cells and subfertility in both sexes47; loss of BMP15 in sheep causes a block at the primary follicle stage and infertility48. Studies in XO mice suggest that abnormal chromosomal segregation contributes to germ cell problems49, indicating that multiple factors are responsible for these human ovarian abnormalities.
Death in the germline
In females, quiescent primordial follicles (a non-growing oocyte surrounded by squamous granulosa cells) form during prenatal life in humans and post-natally in mice. Recruitment of these follicles during ovarian folliculogenesis permits further growth and development of oocytes. In males, spermatogenesis is characterized by three specific functional phases: proliferation, meiosis and spermiogenesis. The proliferative phase in the testis begins early in embryonic development, and with the exception of a brief period when spermatogonia arrest during late foetal and early postnatal life, they proliferate actively throughout life. Spermatogonial stem cells were one of the first recognized examples of adult stem cells capable of rejuvenating spermatogenesis after toxic insult50,51. In contrast, the formation of primordial follicles in females defines a finite endowment of oocytes. Between the time of ovary development and reproductive sequence, there is a precipitous drop in the number of oocytes. In humans, seven million foetal germ cells at 20 weeks are reduced to two million oocytes at birth, and eventually to 300,000 at puberty52,53. Thus, factors that prenatally and postnatally regulate germ cell survival in the ovary can prolong the reproductive lifespan.
The spermatogonia proliferation rate, the highest in the body, is well regulated; thus, it is not surprising that genes involved in growth (for example, Kit, Csf and Bmp8b) and apoptosis are also required for normal spermatogonia (Fig. 2). This stage of spermatogenesis is also noteworthy for its inefficiency; in rats, 75% of spermatogonia do not survive to become mature sperm54. A balance of anti-apoptotic members of the BCL2 family (that is, BCL2, BCL6, BCLX, and BCLW) and the pro-apoptotic BAX protein is extremely important in the regulation of germ cell survival prenatally and postnatally in both sexes, and in response to toxins in the ovary55,56,57. It is possible that defects in this delicate balance of cell proliferation and cell death contribute to the clinical pathology of hypospermatogenesis (all cellular elements of the testis are present, but at low cellularity). In the mouse, an absence of BCLX results in a complete loss of germ cells before birth in both males and females; furthermore, a lack of BCLW results in a partial reduction of PGCs in females, whereas an absence of BCL2 results in only decreased oocyte numbers postnatally12,58,59. Absence of either BAX or BCLW causes male infertility, and absence of BCL6 causes male subfertility, again suggesting that a balance of apoptotic/anti-apoptotic factors is necessary for normal spermatogenesis. In contrast, a prolonged female reproductive lifespan occurs in the absence of BAX in mice, consistent with its pro-apoptotic role60. Polycyclic aromatic hydrocarbons in cigarette smoke and air pollution bind to the aryl hydrocarbon receptor to stimulate transcriptional activation of Bax, thereby enhancing apoptosis and oocyte loss61. In the future, factors that inhibit the BAX pathways or stimulate the anti-apoptotic pathways could prolong the reproductive lifespans of women.
Meiosis, recombination, the integrity of the genome and more death
Meiosis is a process of cell division that is unique to germ cells and is required for the production of healthy haploid gametes (reviewed in greater detail in ref. 62). This process is evolutionarily important for both the integrity and diversity of species, as recombination of homologous chromosomes occurs during prophase of the first meiotic division, helping to orient chromosomes on the meiotic spindle, as well as introducing genetic variability. Male spermatogenesis is initiated postnatally (in mice at postnatal day 7) and is a continuous process producing spermatozoa. Proliferating spermatogonia differentiate and enter meiosis as spermatocytes. In contrast, oogenesis is initiated prenatally (in mice at embryonic day 13), arrests initially at the diplotene stage of meiotic prophase, resumes with the preovulatory luteinizing hormone (LH) surge and arrests again after the first polar body is released before fertilization.
Despite sexual dimorphism in meiosis, many regulators of the process are common to the germ cells of both sexes. In the absence of these proteins, prophase arrest and accompanying germ cell death occur in male and female germ cells. Infertility in both sexes is observed in knockout mice lacking the recombination and DNA damage/mismatch repair proteins, SPO11, DMC1, ataxia telangiectasia (ATM), MSH4, MLH1, and MSH5 (refs 63–74). Mutations in ATM and Fanconi anaemia (FA) complementation-group-protein genes result in fertility defects in humans and mice of both sexes (Figs 1,2). ATM is involved in DNA metabolism and cell cycle checkpoint control75, whereas FA is a hereditary chromosomal instability syndrome76. FA men are hypogonadal, oligospermic and rarely fertile; FA women can experience premature ovarian failure in their 20s. Several FA mouse models have been created and display reduced fertility77. Thus, similar mechanisms for germline monitoring are conserved in mammals and in both sexes.
When the germline 'proofreading' system goes awry in an otherwise 'normal' individual, there are major consequences. Despite a normal somatic karyotype, sperm collected from oligospermic men exhibit an increased frequency of chromosomal abnormalities78,79. Aneuploidy is the most common genetic abnormality in humans80, and the common trisomies (for example, trisomy 21 (Down's syndrome and trisomy 18)) arise primarily in the children of ageing women through non-disjunction defects during the first meiotic division81. These findings are exemplified in mice lacking synaptonemal complex protein 3 (SYCP3), which functions in synapsis (pairing) of the homologous chromosomes during meiosis. Sycp3 knockout males are infertile; females are subfertile, exhibiting loss of aneuploid embryos82,83. Interestingly, germline deletions resulting in Duchenne muscular dystrophy (DMD) more often arise during oogenesis, whereas DMD point mutations result more commonly from spermatogenic failure84. This suggests that some proofreading mechanisms during male and female gametogenesis may differ (see also ref. 80).
Hormones take control
After sexual maturity, all stages of spermatogenesis (male) and folliculogenesis (female) are observed, the end result in each case being gamete production. Hypothalamic pituitary control of gonadal somatic cells is critical for fertility in all mammals and in both sexes (Fig. 3; reviewed in refs 85–88). Gonadotropin releasing hormone (GnRH) from the hypothalamus regulates the pituitary gonadotrope production of follicle stimulating hormone (FSH) and LH, α–β heterodimers that share a common α subunit with placental human chorionic gonadotropin (hCG) and pituitary thyroid stimulating hormone (TSH). Spontaneous deletion of the hypothalamic GnRH-encoding sequences in mice (that is, hpg), mutation of the human GnRH processing enzyme gene (PC1), disruption of developmental migration of the GnRH neurons in human Kallman Syndrome, or mutation of the GnRH receptor gene (expressed in gonadotropes), results in hypogonadotropic hypogonadism (HHG) and infertility (Fig. 1). Loss-of-function mutations in the pituitary-expressed FSHβ genes and gonadal-expressed FSH receptor genes decrease testis size and spermatozoa counts in men and male mice, and cause a block in folliculogenesis and infertility in women and female mice. This emphasizes the conservation and importance of these signalling pathways. Similarly, pituitary gland development and downstream steroidogenic pathways are conserved in humans and mice and are critical for fertility in both sexes. For example, a homozygous Prop1 missense mutation causes multiple pituitary defects in the Ames dwarf mouse, including defects in gonadotrope differentiation and infertility in all female and most male mice. Similarly, human PROP1 mutations cause combined pituitary hormone deficiency, including HHG and infertility (Fig. 1).
Members of the steroid receptor superfamily and their transcriptional coactivators (for example, AR, ER, PR, RXRβ, SF1, DAX1, and SRC1) are pivotal in the regulation of reproductive function. Disruption of any of the genes involved in androgen biosynthesis, metabolism and action negatively impact male development, spermatogenesis and function. Spontaneous mutations of the X-linked androgen receptor gene in XY mice (that is, tfm (testicular feminization)) and humans result in individuals with abnormal testes, no ductal system and external female genitalia10,89 (http://ww2.mcgill.ca/androgendb). Absence of steroid 5α reductase, which converts testosterone to dihydrotestosterone, results in external female genitalia, prostate absence in XY humans and developmental disruption of the male ductal system (that is, seminal vesicles and prostate)90,91. Similarly, mutations in the orphan nuclear receptors, steroidogenic factor-1 (SF1) and DAX1, have been described in mice and humans; mutations in DAX1 cause almost universal HHG in adult humans (Fig. 1).
Not surprisingly, oestrogen and progesterone are key to early folliculogenesis and corpus luteum maintenance of early pregnancy in the female92. Targeted deletion of oestrogen receptor α in mice revealed that it is also required for male fertility and for male and female sexual behaviour93. Similarly, the progesterone receptor (also required for female fertility) is important in sexual behaviour in the mouse94. In the evaluation of the infertile couple, assessment of circulating hormone levels (FSH, LH, testosterone, prolactin and free testosterone in the male; FSH, LH, oestradiol and progesterone levels in the female) can provide important information concerning the function of the hypothalamic–pituitary–gonadal axis and the presence of endocrinopathies.
Spermatogenesis has many unique players
Spermatogenesis requires not only the appropriate hormonal milieu, but also autocrine, paracrine and juxtacrine signalling between the various testicular compartments. The testis is composed of an interstitial cell compartment with androgen-producing Leydig cells, and the seminiferous tubule containing Sertoli cells, peritubular myoid cells and germ cells. Whereas follicles are recruited each cycle to enter the ovulatory pathway in females, all stages of spermatogenesis are present at any one time in different tubules within the testis. Thus, the wave of spermatogenesis resulting in development of mature sperm is a spatial cycle rather than a temporal one. The importance of growth factors and cytokines, their receptors and signal transduction pathways to gametogenesis cannot be underestimated. For example, deletion of mouse Desert hedgehog (Dhh) affects testicular development, resulting in anastomatic seminiferous tubules and an absence of adult Leydig cells. Similarly, the insulin-like growth factor (Igf1) null male mouse is characterized by vestigal vas deferens, prostate and seminal vesicles, caused by a steroidogenic Leydig cell defect.
Once male germ cells complete meiosis to achieve a haploid chromosomal complement, they are called spermatids. Spermatids undergo a process of cellular differentiation known as spermiogenesis, progressing from round to elongating to elongated spermatids, culminating in the development of spermatozoa. Many male-specific genes are involved in this extensive cellular remodelling and concomitant condensation of the chromatin (for example, Tnp1, Tnp2, Prm1, Prm2, Theg and Hsp60-2; see Fig. 2). In common with many of the Y chromosome genes that encode RNA-binding proteins and are implicated in human infertility, an absence of similar proteins in the mouse, such as STYX, disrupts spermatid development95. After spermiogenesis and release of the spermatozoa from the Sertoli cells into the seminiferous tubule lumen, acquisition of motility occurs during transit through the epididymis and capacitation occurs in the oviduct (fallopian tubes) of the female genital tract. Both of these processes are required for effective penetration of the zona pellucida and egg.
In the evaluation of the infertile male, a semen sample is ordered to determine sperm count, motility and morphology. Some laboratories perform sperm function tests that predict defects in sperm–zona or egg interaction, or in penetration. However, semen analysis is not a definitive test of the fertility potential of an individual unless there are no sperm in the ejaculate. This is also true in mice. For example, FSH-β mutant mice exhibit reduced sperm counts, but fertility is normal96. Conversely, many mouse models are infertile and demonstrate abnormal sperm function, sperm motility (for example, ApoB, CatSper, Dnahc1, Hmgb2 and Ros knockout mice), or morphology (for example, Tnp2, Tnp1 and Sperm1 knockout mice) with no detrimental effect on sperm count. In addition, targeted deletion of the Ace, Adam2, Adam3, calmegin, Pc4, Spam1, Spnr, Trg26, Jdf2 or Mdhc7 genes results in normal sperm count, motility and morphology; however, sperm function is defective (Fig. 2). As a majority of unexplained cases of infertility in human males result from spermatogenic defects (Fig. 3), the homologues of the above-described mouse genes are actively being pursued for their possible roles in human infertility.
Chromosomal abnormalities are observed in 5.8% of infertile males97 and more commonly involve sex chromosomes (4.2%), as opposed to autosomes (1.5%; Fig. 1). In addition to SRY, other Y chromosome genes are required for spermatogenesis. This became obvious in the XX Sxr male mouse and the XX Sry transgene-positive male mouse, which are sex-reversed, but display spermatogenesis blocks31. Similarly, a region at Yq11 that is deleted in several infertile men was termed the azoospermia factor (AZF) region98. In general, the reported incidence of deletions in this region in severe oligospermic/azoospermicmen is 10–18% and varies depending on the stringency of diagnostic classification99. This region (now further subdivided into AZFa, AZFb and AZFc), contains several genes involved in spermatogenesis, including deleted in azoospermia (DAZ)100,101. In the mouse, disruption of the testis-expressed Dazla homologue gene on chromosome 17 abrogates gamete production. Other putative evolutionarily conserved spermatogenesis genes have been mapped to Y chromosome regions commonly deleted in infertile men (reviewed in ref. 99). Mutations in the human gene USP9Y (ubiquitin-specific protease 9, Y chromosome or DFFRY), a homologue of the D. melanogaster development Fat facets gene21, cause infertility102. Functional analysis of additional Y chromosome genes in the mouse has been complicated by the presence of multiple copies or X-chromosome homologues, as well as technical difficulties related to the low efficiency of Y chromosome homologous recombination in embryonic stem cells. However, it is expected that the recent and exciting technological breakthroughs achieved by Bishop and colleagues103, who developed a method for successful gene targeting of the Y chromosome in embryonic stem cells, and the development of an embryonic stem cell line104 that will facilitate germ line transmission of Y chromosome targeted genes, will rapidly translate into an enhanced understanding of the role of specific Y chromosome genes in male reproductive function.
No crosstalk in females, no folliculogenesis progression
Although several proteins are involved in ovarian folliculogenesis, meiosis, and oocyte survival, oocyte–somatic cell crosstalk is especially critical for release of a fertilizable egg (Fig. 4 and ref. 105). Without the helix-loop-helix protein factor in the germline α (FIGα), pre-granulosa (somatic) cells fail to form a monolayer around individual primordial oocytes, resulting in rapid germ cell depletion from the neonatal mouse ovary and sexual infantilism106. Similarly, oocyte growth during folliculogenesis is regulated by signalling of granulosa KITL to the oocyte-expressed KITR46. KITL expression is controlled by both hormonal (FSH) and oocyte (growth differentiation factor-9 (GDF-9)) factors107. In the absence of the TGF-β superfamily ligand GDF-9 in mice108 or its close oocyte-specific homologue, BMP-15, in sheep48, an arrest in folliculogenesis at the primary follicle stage is observed (Fig. 5). FSH has no effect on the 'arrested' primary follicles of Gdf9 knockout ovaries108, suggesting that GDF-9 allows the granulosa cells to grow and acquire the competence to respond to FSH. Absence of GDF-9 results in elevated levels of KITL109, which signals back to markedly increase oocyte size108. These findings were confirmed by studies showing that recombinant GDF-9 downregulates levels of Kitl mRNA107. In addition to oocyte factors, FSH96 functions with IGF-1 (by stimulating cyclin D2 and oestrogen synthesis)110,111 to regulate the growth of the follicle through the pre-ovulatory stage (Fig. 5). In pre-ovulatory follicles, LH, in conjunction with the oocyte-secreted proteins GDF-9 and BMP-15, signals to somatic cells to initiate ovulation of a healthy cumulus-oocyte complex (COC). Thus, important crosstalk between somatic cells and oocytes, as well as endocrine signalling, is necessary for normal folliculogenesis and ovulation.
Post-fertilization, Mater (maternal antigen that embryos require) and several other genes (including Dnmt1o, Pms2 and Hsf1) (Fig. 4), have been identified by knockout mouse studies as maternal effect (oocyte-synthesized) genes that are essential for development112. The human homologue of Mater has been identified and may be a candidate gene for premature ovarian failure113. Similarly, several uterine proteins are required for implantation (Fig. 4 and ref. 114). Thus, these studies have pinpointed multiple putative diagnostic targets in women who present with infertility.
In women, several syndromes — including ovarian failure and infertility — are attributed to autosomal recessive mutations88,115. Blepharophimosis/ptosis/epicanthus inversus syndrome, the only autosomal dominant disorder associated with premature ovarian failure (POF), is caused by mutations in the forkhead transcription factor gene (FOXL2)116. Expansion of a CGG trinucleotide repeat of the Xq27.3 fragile X mental retardation gene (FMR1) to over 200 repeats is the most common heritable cause of mental retardation. The unstable premutation FMR1 allele (60–199 CGG repeats) causes POF in 21% of heterozygote carriers and increased twin pregnancies117. Furthermore, 2% of sporadic cases and 14% of familial cases of POF are associated with the premutation allele. The pathophysiology of the premutation allele in POF is unknown, but this finding clearly represents a step forward in identifying a genetic locus for POF. To date, all other identified single gene autosomal dominant or recessive mutations with isolated infertility in humans affect steroidogenic or gonadotropin pathways, often in both sexes. However, many candidate genes await analysis in human idiopathic infertility cases.
Descent of the testis and problems with sperm transit
Testis determination and gametogenesis are necessary, but not sufficient, for male fertility, as testicular descent down the inguinal canal into the scrotum, in addition to the development of the genital tract and penis, are also critical. Mutations of the mouse genes Insl3, Great (G-protein coupled receptor that affects testicular descent; a possible relaxin receptor) and Hoxa10 (refs 118–122) result in male infertility secondary to cryptorchidism. The second phase of testicular descent requires androgens and a functional androgen receptor. In humans, cryptorchidism results from anti-Mullerian hormone (AMH) deficiency caused by obstruction of the genital tract.
Gonadal sex determines secondary duct differentiation. In females, the Müllerian duct differentiates into the oviducts, uterus and upper portion of the vagina; in males, the Wolffian duct differentiates into epididymis, vas deferens and seminal vesicles19,23,123. The Müllerian duct regresses in response to prenatal production of testicular AMH, and Wolffian duct development requires testosterone. Differentiation of the prostate and male external genitalia is driven by dihydrotestosterone, a product of the conversion of testosterone by 5-α reductase. Mutations in genes that affect steroidogenesis (for example, P450 aromatase (CYP19) and 5-α reductase) and steroid signalling pathways (for example, oestrogen receptor α (ERα) and androgen receptor) have deleterious effects on genital tract development and function in the male. Thus, it follows that pseudohermaphroditism occurs as a result of defects in genes involved in gonad formation (for example, SF1 and WT1). Mutations of the AMH or AMH receptor genes result in persistence of Müllerian duct syndrome (PMDS), resulting in obstructive azoospermia and fertility defects in men, male dogs and mice (Fig. 1 and ref. 123).
One to two per cent of infertile men present with obstructive azoospermia caused by congenital bilateral absence of the vas deferens (CBAVD), as a result of mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene1,124. These CBAVD patients successfully father offspring because microsurgical epididymal sperm aspiration yields 'normal' sperm for in vitro fertilization (IVF). Male fertility also may be compromised by epididymal, ejaculatory or erectile dysfunction, as well as by other congenital anomalies.
New technologies and perspectives
Genome, gene and cDNA sequences are being deposited into public databases (for example, the National Center for Biotechnology Information (NCBI; http://www.ncbi.nlm.nih.gov) or the Wellcome Trust Sanger Institute (http://www.sanger.ac.uk)) with amazing speed. Furthermore, programs to search these databases, such as BLAST (http://www.ncbi.nlm.nih.gov/blast) and the Unigene database at NCBI, are helping scientists to use this wealth of information. In particular, sequences unique to mammalian germ cells have been identified using an in silico subtraction (electronic database) approach125. For example, GASZ (germ-cell-specific and ankyrin repeat, sterile α-motif and basic leucine-zipper-containing protein) was identified as a novel evolutionarily-conserved germ cell-expressed gene lying adjacent to the CFTR gene in human, chimpanzee, baboon, cow, rat and mouse126. Functional expression and sequence data is also being collated into collections, such as the Ovarian Kaleidoscope database (http://ovary.stanford.edu), the Male Reproductive Genetics database (http://mrg.genetics.washington.edu/home.html) and the GermOnline database (http://germonline.igh.cnrs.fr). With the use of microarrays for expression analysis of reproductive tissues127, these 'bits' of data will increase exponentially. Therefore, there is an urgent need for bioinformatics advances to facilitate compiling and sorting through this wealth of in silico information for future applications in the clinic.
Technological procedures and advances in the clinic are also wrought with some controversies and dilemmas. Of particular importance, the application of assisted reproductive technologies (ART) for severe male and female factor infertility serves to not only overcome sterility, but bypasses natural barriers to the inheritance of defective genes. This results in considerable concern that genetic defects will be transmitted to the next generation. Among these controversial treatments are ICSI (intracytoplasmic sperm injection), cytoplasmic (ooplasmic) transfer, round spermatid nuclear injection (ROSNI or ROSI) and reproductive cloning (described in more detail by Schatten in this issue128).
These technologies have prompted significant debates concerning their morality and safety. However, even a United States government moratorium on human cloning has not deterred renegade scientists overseas from actively engaging in this research, which could result in a potentially disastrous outcome.
Conclusions
To date, diagnosis of infertility in the clinic has been hindered by our relatively poor understanding of the underlying molecular mechanisms. Although investigators have attempted to translate findings in animal models to humans by searching for gene mutations/deletions in idiopathic infertility patients, in general, these investigations have not been fruitful. Given the large number of candidate evolutionarily conserved 'fertility' genes yet to be discovered or identified from mutant mouse studies, and the overall complexity of the reproductive system in general, proper diagnosis and treatment of these patients will await the development of more sophisticated and rapid technologies. Finally, if mutation of a gene in mice or humans results in infertility, the protein product of that gene may be a future target for novel contraceptives that are designed to transiently or permanently cause infertility.
References
Anguiano, A. et al. Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. J. Am. Med. Assoc. 267, 1794–1797 (1992).
Zinn, A.R. & Ross, J.L. Molecular analysis of genes on Xp controlling Turner syndrome and premature ovarian failure (POF). Semin. Reprod. Med. 19, 141–146 (2001).
Burns, K., DeMayo, F.J. & Matzuk, M.M. Reproductive Medicine: Molecular, Cellular and Genetic Fundamentals (ed. Fauser, B.C.J.M.) Ch 10 (Parthenon Publishing, Boca Raton, FL, 2002).
Lipshultz, L. & Howards, S. Infertility in the male (Mosby Press, St. Louis, MO, 1997).
Crosignani, P.G. & Rubin, B.L. Optimal use of infertility diagnostic tests and treatments. The ESHRE Capri Workshop Group. Hum. Reprod. 15, 723–732 (2000).
Transgenics in Endocrinology 485 (Humana Press, Totowa, NJ, 2001).
Balling, R. ENU mutagenesis: analyzing gene function in mice. Annu. Rev. Genomics Hum. Genet. 2, 463–492 (2001).
Capecchi, M.R. Generating mice with targeted mutations. Nature Med. 7, 1086–1090 (2001).
Mason, A.J. et al. Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-β. Nature 318, 659–663 (1985).
Charest, N.J. et al. A frameshift mutation destabilizes androgen receptor messenger RNA in the Tfm mouse. Mol. Endocrinol. 5, 573–581 (1991).
Yanaka, N. et al. Insertional mutation of the murine kisimo locus caused a defect in spermatogenesis. J. Biol. Chem. 275, 14791–14794 (2000).
Ross, A.J. et al. Testicular degeneration in Bclw-deficient mice. Nature Genet. 18, 251–256 (1998).
Komada, M., McLean, D.J., Griswold, M.D., Russell, L.D. & Soriano, P. E-MAP-115, encoding a microtubule-associated protein, is a retinoic acid-inducible gene required for spermatogenesis. Genes Dev. 14, 1332–1342 (2000).
Pires-daSilva, A. et al. Mice deficient for spermatid perinuclear RNA-binding protein show neurologic, spermatogenic, and sperm morphological abnormalities. Dev. Biol. 233, 319–328 (2001).
Renfree, M.B. & Shaw, G. Germ cells, gonads and sex reversal in marsupials. Int. J. Dev. Biol. 45, 557–567 (2001).
Braat, A.K., Speksnijder, J.E. & Zivkovic, D. Germ line development in fishes. Int. J. Dev. Biol. 43, 745–760 (1999).
Saffman, E.E. & Lasko, P. Germline development in vertebrates and invertebrates. Cell Mol. Life Sci. 55, 1141–1163 (1999).
Starz-Gaiano, M. & Lehmann, R. Moving towards the next generation. Mech. Dev. 105, 5–18 (2001).
Gilbert, S.F. Developmental Biology (Sinauer Associates Inc., Sunderland, 1997).
Tanaka, S.S. et al. The mouse homolog of Drosophila Vasa is required for the development of male germ cells. Genes Dev. 14, 841–853 (2000).
Jones, M.H. et al. The Drosophila developmental gene fat facets has a human homologue in Xp11.4 which escapes X-inactivation and has related sequences on Yq11.2. Hum. Mol. Genet. 5, 1695–1701 (1996).
Eberhart, C.G., Maines, J.Z. & Wasserman, S.A. Meiotic cell cycle requirement for a fly homologue of human Deleted in Azoospermia. Nature 381, 783–785 (1996).
Whitworth, D.J. & Behringer, R.R. Contemporary Endocrinology: Transgenics in Endocrinology (eds Matzuk, M.M., Brown, C.W. & Kumar, T.R.) 19–39 (Humana Press, Totowa, NJ, 2001).
Maduro, M. & Lamb, D. Understanding the new genetics of male infertility. J. Urol. (in the press).
Yao, H.H., Tilmann, C., Zhao, G.Q. & Capel, B. The battle of the sexes: opposing pathways in sex determination. Novartis Found. Symp. 244, 187–198 (2002).
Jacobs, P.A. & Strong, J.A. A case of human intersexuality having a possible XXY sex-determining mechanism. Nature 183, 302–303 (1959).
Ford, C.E., Jones, K.W., Polani, P.E., de Almeida, J.C. & Briggs, J.H. A sex-chromosome anomaly in a case of gonadal dysgenesis (Turner's syndrome). Lancet 7075, 711–713 (1959).
Welshons, W.J. & Russell, L.B. The Y-chromosome as the bearer of male determining factors in the mouse. Proc. Natl Acad. Sci. USA 45, 560–566 (1959).
Sinclair, A.H. et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346, 240–244 (1990).
Gubbay, J. et al. A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature 346, 245–250 (1990).
Koopman, P., Gubbay, J., Vivian, N., Goodfellow, P. & Lovell-Badge, R. Male development of chromosomally female mice transgenic for Sry . Nature 351, 117–121 (1991).
Cameron, F.J. & Sinclair, A.H. Mutations in SRY and SOX9: testis-determining genes. Hum. Mut. 9, 388–395 (1997).
Zanaria, E. et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372, 635–641 (1994).
Foster, J.W. et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372, 525–530 (1994).
Wagner, T. et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79, 1111–1120 (1994).
Sudbeck, P., Schmitz, M.L., Baeuerle, P.A. & Scherer, G. Sex reversal by loss of the C-terminal transactivation domain of human SOX9. Nature Genet. 13, 230–232 (1996).
Shi, Q. & Martin, R.H. Multicolor fluorescence in situ hybridization analysis of meiotic chromosome segregation in a 47,XYY male and a review of the literature. Am. J. Med. Genet. 93, 40–46 (2000).
De Braekeleer, M. & Dao, T.N. Cytogenetic studies in male infertility: a review. Hum. Reprod. 6, 245–250 (1991).
Chiquoine, A.D. The identification, origin and migration of the primordial germ cells in the mouse embryo. Anat. Rec. 118, 135–146 (1954).
Ginsburg, M., Snow, M.H. & McLaren, A. Primordial germ cells in the mouse embryo during gastrulation. Development 110, 521–528 (1990).
Chang, H. & Matzuk, M.M. Smad5 is required for mouse primordial germ cell development. Mech. Dev. 104, 61–67 (2001).
Lawson, K.A. et al. Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev. 13, 424–436 (1999).
Tremblay, K.D., Dunn, N.R. & Robertson, E.J. Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 128, 3609–3621 (2001).
Ying, Y., Liu, X.-M., Marble, A., Lawson, K.A. & Zhao, G.-Q. Requirement of BMP8b for the generation of primordial germ cells in the mouse. Mol. Endocrinol. 14, 1053–1063 (2000).
Wylie, C. Germ cells. Curr. Opin. Genet. Dev. 10, 410–413 (2000).
Donovan, P. & de Miguel, M.P. Transgenics in Endocrinology (eds Matzuk, M.M., Brown, C.W. & Kumar, T.R.) 147–163 (Humana Press, Totowa, NJ, 2001).
Luoh, S.-W. et al. Zfx mutation results in small animal size and reduced germ cell number in male and female mice. Development 124, 2275–2284 (1997).
Galloway, S.M. et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nature Genet. 25, 279–283 (2000).
Burgoyne, P.S. & Baker, T.G. Perinatal oocyte loss in XO mice and its implications for the aetiology of gonadal dysgenesis in XO women. J. Reprod. Fertil. 75, 633–645 (1985).
Huckins, C. & Oakberg, E.F. Morphological and quantitative analysis of spermatogonia in mouse testes using whole mounted seminiferous tubules. II. The irradiated testes. Anat. Rec. 192, 529–542 (1978).
Brinster, R.L. Germline stem cell transplantation and transgenesis. Science 296, 2174–2176 (2002).
Baker, T. A quantitative and cytological study of germ cells in human ovaries. Proc. R. Soc. Lond. B 158, 417–433 (1963).
Faddy, M.J., Gosden, R.G., Gougeon, A., Richardson, S.J. & Nelson, J.F. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum. Reprod. 7, 1342–1346 (1992).
Huckins, C. The morphology and kinetics of spermatogonial degeneration in normal adult rats: an analysis using a simplified classification of the germinal epithelium. Anat. Rec. 190, 905–926 (1978).
Ross, A.J. & MacGregor, G.R. Transgenics in Endocrinology (eds Matzuk, M.M., Brown, C.W. & Kumar, T.R.) 115–145 (Humana Press, Totowa, NJ, 2001).
Matzuk, M.M. Eggs in the balance. Nature Genet. 28, 300–301 (2001).
Tilly, J.L. Commuting the death sentence: how oocytes strive to survive. Nature Rev. Mol. Cell Biol. 2, 838–848 (2001).
Ratts, V.S., Flaws, J.A., Kolp, R., Sorenson, C.M. & Tilly, J.L. Ablation of bcl-2 gene expression decreases the numbers of oocytes and primordial follicles established in the post-natal female mouse gonad. Endocrinology 136, 3665–3668 (1995).
Rucker, E.B. 3rd et al. Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis. Mol. Endocrinol. 14, 1038–1052 (2000).
Perez, G.I. et al. Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency. Nature Genet. 21, 200–203 (1999).
Matikainen, T. et al. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nature Genet. 28, 355–360 (2001).
Cohen, P.E. & Pollard, J.W. Regulation of meiotic recombination and prophase I progression in mammals. Bioessays 23, 996–1009 (2001).
Baudat, F., Manova, K., Yuen, J.P., Jasin, M. & Keeney, S. Chromosome synapsis defects and sexually dimorphic meiotic progression in mice lacking Spo11. Mol. Cell 6, 989–998 (2000).
Romanienko, P.J. & Camerini-Otero, R.D. The mouse Spo11 gene is required for meiotic chromosome synapsis. Mol. Cell 6, 975–987 (2000).
Yoshida, K. et al. The mouse RecA-like gene Dmc1 is required for homologous chromosome synapsis during meiosis. Mol. Cell 1, 707–718 (1998).
Pittman, D.L. et al. Meiotic prophase arrest with failure of chromosome synapsis in mice deficient for Dmc1, a germline-specific RecA homolog. Mol. Cell 1, 697–705 (1998).
Xu, X., Toselli, P.A., Russell, L.D. & Seldin, D.C. Globozoospermia in mice lacking the casein kinase II α′ catalytic subunit. Nature Genet. 23, 118–121 (1999).
Barlow, C. et al. Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell 86, 159–171 (1996).
Barlow, C. et al. Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I. Development 125, 4007–4017 (1998).
Kneitz, B. et al. MutS homolog 4 localization to meiotic chromosomes is required for chromosome pairing during meiosis in male and female mice. Genes Dev. 14, 1085–1097 (2000).
Edelmann, W. et al. Meitoic pachytene arrest in MLH1-deficient mice. Cell 85, 1125–1134 (1996).
Edelmann, W. et al. Mammalian MutS homologue 5 is required for chromosome pairing in meiosis. Nature Genet. 21, 123–127 (1999).
Roest, H.P. et al. Inactivation of the HR6B ubiquitin-conjugating DNA repair enzyme in mice causes male sterility associated with chromatin modification. Cell 86, 799–810 (1996).
Xu, Y. et al. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10, 2411–2422 (1996).
Gatti, R.A. The Genetic Basis of Human Cancer (eds Vogelstein, B. & Kinzler, K.W.) 275–300 (McGraw-Hill, New York, 1998).
Auerbach, A.D., Buchwald, M. & Joenje, H. The genetic basis of human cancer (eds Vogelstein, B. & Kinzler, K.W.) 317–332 (McGraw-Hill, New York, 1998).
Wong, J.C. & Buchwald, M. Disease model: Fanconi anemia. Trends Mol. Med. 8, 139–142 (2002).
Moosani, N. et al. Chromosomal analysis of sperm from men with idiopathic infertility using sperm karyotyping and fluorescence in situ hybridization. Fertil. Steril. 64, 811–817 (1995).
Bischoff, F.Z., Nguyen, D.D., Burt, K.J. & Shaffer, L.G. Estimates of aneuploidy using multicolor fluorescence in situ hybridization on human sperm. Cytogenet. Cell. Genet. 66, 237–243 (1994).
Hunt, P.A. & Hassold, T.J. Sex matters in meiosis. Science 296, 2181–2183 (2002).
Angell, R. First-meiotic-division nondisjunction in human oocytes. Am. J. Hum. Genet. 61, 23–32 (1997).
Yuan, L. et al. Female germ cell aneuploidy and embryo death in mice lacking the meiosis-specific protein SCP3. Science 296, 1115–1118 (2002).
Yuan, L. et al. The murine SCP3 gene is required for synaptonemal complex assembly, chromosome synapsis, and male fertility. Mol. Cell 5, 73–83 (2000).
Grimm, T. et al. On the origin of deletions and point mutations in Duchenne muscular dystrophy: most deletions arise in oogenesis and most point mutations result from events in spermatogenesis. J. Med. Genet. 31, 183–186 (1994).
Burns, K.H. & Matzuk, M.M. Genetic models for the study of gonadotropin actions. Endocrinology 143, 2823–2835 (2002).
Achermann, J.C., Weiss, J., Lee, E.J. & Jameson, J.L. Inherited disorders of the gonadotropin hormones. Mol. Cell Endocrinol. 179, 89–96 (2001).
Themmen, A.P.N. & Huhtaniemi, I.T. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary–gonadal function. Endocr. Rev. 21, 551–583 (2000).
Adashi, E.Y. & Hennebold, J.D. Single-gene mutations resulting in reproductive dysfunction in women. N. Engl. J. Med. 340, 709–718 (1999).
Brown, T.R. et al. Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome. Proc. Natl Acad. Sci. USA 85, 8151–8155 (1988).
Andersson, S., Berman, D.M., Jenkins, E.P. & Russell, D.W. Deletion of steroid 5 α-reductase 2 gene in male pseudohermaphroditism. Nature 354, 159–161 (1991).
Mahendroo, M.S., Cala, K.M., Hess, D.L. & Russell, D.W. Unexpected virilization in male mice lacking steroid 5 α-reductase enzymes. Endocrinology 142, 4652–4662 (2001).
Couse, J.F. & Korach, K.S. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev. 20, 358–417 (1999).
Eddy, E.M. et al. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 137, 4796–4805 (1996).
Lydon, J.P. et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9, 2266–2278 (1995).
Wishart, M.J. & Dixon, J.E. The archetype STYX/dead-phosphatase complexes with a spermatid mRNA-binding protein and is essential for normal sperm production. Proc. Natl Acad. Sci. USA 99, 2112–2117 (2002).
Kumar, T.R., Wang, Y., Lu, N. & Matzuk, M.M. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nature Genet. 15, 201–204 (1997).
Johnson, M.D. Genetic risks of intracytoplasmic sperm injection in the treatment of male infertility: recommendations for genetic counseling and screening. Fertil. Steril. 70, 397–411 (1998).
Tiepolo, L. & Zuffardi, O. Localization of factors controlling spermatogenesis in the nonfluorescent portion of the human Y chromosome long arm. Hum. Genet. 34, 119–124 (1976).
Foresta, C., Moro, E. & Ferlin, A. Y chromosome microdeletions and alterations of spermatogenesis. Endocr. Rev. 22, 226–239 (2001).
Ruggiu, M. et al. The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. Nature 389, 73–76 (1997).
Reijo, R. et al. Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nature Genet. 10, 383–393 (1995).
Sun, C. et al. An azoospermic man with a de novo point mutation in the Y-chromosomal gene USP9Y . Nature Genet. 23, 429–432 (1999).
Rohozinski, J., Agoulnik, A.I., Boettger-Tong, H.L. & Bishop, C.E. Successful targeting of mouse Y chromosome genes using a site-directed insertion vector. Genesis 32, 1–7 (2002).
Simpson, E.M. et al. Novel Sxra ES cell lines offers hope for Y chromosome gene-targeted mice. Genesis 33, 62–66 (2002).
Matzuk, M.M., Burns, K., Viveiros, M.M. & Eppig, J. Intercellular communication in the mammalian ovary: oocytes carry the conversation. Science 296, 2178–2180 (2002).
Soyal, S.M., Amleh, A. & Dean, J. FIGα, a germ cell-specific transcription factor required for ovarian follicle formation. Development 127, 4645–4654 (2000).
Joyce, I.M., Clark, A.T., Pendola, F.L. & Eppig, J.J. Comparison of recombinant growth differentiation factor-9 and oocyte regulation of KIT ligand messenger ribonucleic acid expression in mouse ovarian follicles. Biol. Reprod. 63, 1669–1675 (2000).
Dong, J. et al. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383, 531–535 (1996).
Elvin, J.A., Yan, C., Wang, P., Nishimori, K. & Matzuk, M.M. Molecular characterization of the follicle defects in the growth differentiation factor-9-deficient ovary. Mol. Endocrinol. 13, 1018–1034 (1999).
Robker, R.L. & Richards, J.S. Hormonal control of the cell cycle in ovarian cells: proliferation versus differentiation. Biol. Reprod. 59, 476–482 (1998).
Couse, J.F. et al. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors α and β. Science 286, 2328–2331 (1999).
Tong, Z.B. et al. Mater, a maternal effect gene required for early embryonic development in mice. Nature Genet. 26, 267–268 (2000).
Tong, Z.B., Bondy, C.A., Zhou, J. & Nelson, L.M. A human homologue of mouse Mater, a maternal effect gene essential for early embryonic development. Hum. Reprod. 17, 903–911 (2002).
Lim, H. et al. Molecules in blastocyst implantation: uterine and embryonic perspectives. Vitamins Hormones 64, 43–76 (2002).
Simpson, J.L. & Rajkovic, A. Ovarian differentiation and gonadal failure. Am. J. Med. Genet. 89, 186–200 (1999).
Crisponi, L. et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nature Genet. 27, 159–166 (2001).
Kenneson, A. & Warren, S.T. The female and the fragile X reviewed. Semin. Reprod. Med. 19, 159–165 (2001).
Nef, S. & Parada, L.F. Cryptorchidism in mice mutant for Insl3. Nature Genet. 22, 295–299 (1999).
Overbeek, P.A. et al. A transgenic insertion causing cryptorchidism in mice. Genesis 30, 26–35 (2001).
Satokata, I., Benson, G. & Maas, R. Sexually dimorphic sterility phenotypes in Hoxa10-deficient mice. Nature 374, 460–463 (1995).
Zimmermann, S. et al. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol. Endocrinol. 13, 681–691 (1999).
Hsu, S.Y. et al. Activation of orphan receptors by the hormone relaxin. Science 295, 671–674 (2002).
Mishina, Y. Contemporary Endocrinology: Transgenics in Endocrinology (eds Matzuk, M.M., Brown, C.W. & Kumar, T.R.) 41–59 (Humana Press, Totowa, NJ, 2001).
Patrizio, P., Asch, R.H., Handelin, B. & Silber, S.J. Aetiology of congenital absence of vas deferens: genetic study of three generations. Hum. Reprod. 8, 215–220 (1993).
Rajkovic, A., Yan, C., Klysik, M. & Matzuk, M.M. Discovery of germ cell-specific transcripts by expressed sequence tag database analysis. Fertil. Steril. 76, 550–554 (2001).
Yan, W. et al. Identification of Gasz, an evolutionarily conserved gene expressed exclusively in germ cells and encoding a protein with four ankyrin repeats, a sterile-α motif, and a basic leucine zipper. Mol. Endocrinol. 16, 1168–1184 (2002).
Varani, S. et al. Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility. Mol. Endocrinol. 16, 1154–1167 (2002).
Schatten, G.P. Safeguarding ART. Nature Cell Biol. 4 (S1) S19–S22 (2002).
Acknowledgements
The authors thank S. Baker for her expert assistance in manuscript formatting, and R. Behringer, K. Burns, and M.R. Maduro for critical review of the manuscript. We also thank K. Burns and W. Yan for help with the Supplementary Information Table. Studies in the Matzuk and Lamb laboratories on fertility pathways have been supported by the National Institutes of Health (grants HD33438, CA60651, HD32067 and HD36289) and the Specialized Cooperative Centers Program in Reproduction Research (grant HD07495).
Supplementary Information accompanies the paper at www.nature.com/fertility. All gene names are spelled out in full in the Supplementary Information Table.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
41591_2002_BFnmfertilityS41_MOESM1_ESM.pdf
Online table: Mouse mutations causing reproductive defects. Only single mutant defects are described. Fertility defects of unknown gene origin are not described. M, male; F, female; Hetero, heterozygote phenotype
Rights and permissions
About this article
Cite this article
Matzuk, M., Lamb, D. Genetic dissection of mammalian fertility pathways. Nat Med 8 (Suppl 10), S40 (2002). https://doi.org/10.1038/nm-fertilityS41
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm-fertilityS41
This article is cited by
-
A novel homozygote nonsense variant of MSH4 leads to primary ovarian insufficiency and non-obstructive azoospermia
Molecular Biology Reports (2024)
-
Investigation of molecular cryopreservation, fertility potential and microRNA-mediated apoptosis in Oligoasthenoteratozoospermia men
Cell and Tissue Banking (2021)
-
The biology of infertility: research advances and clinical challenges
Nature Medicine (2008)
-
Transcript expression profiles of Takifugu rubripes spermatozoa and eggs by expressed sequence tag analysis
Fish Physiology and Biochemistry (2008)
-
Spermatogonial stem cell transplantation and testicular function
Cell and Tissue Research (2005)